| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-08-31 FY | 2023-12-31 FY | 2022-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $217.00 | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.77M | $1.30M | – | $1.38M | – |
| R&D | $231.59K | $165.62K | $100.80K | $436.40K | $113.25K |
| SG&A | – | $1.13M | – | $964.75K | – |
| Operating Income | -$1.77M | -$1.30M | – | $1.45M | $560.50K |
| Interest Expense | $91.92K | $56.79K | – | $15.71K | $14.07K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$2.24M | -$3.02M | – | -$2.46M | -$965.15K |
| EPS (basic) | -0.0100 | -0.0200 | – | -0.0100 | – |
| EPS (diluted) | -0.0100 | -0.0200 | – | -0.0100 | – |
| Shares (diluted) | $161.82M | $158.61M | – | $286.56M | – |